Susquehanna International Group, LLP Night Hawk Biosciences, Inc. Transaction History

Susquehanna International Group, LLP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.26 - $0.51 $4,078 - $7,999	15,685 New	15,685 $6,000
Q2 2023 Aug 11, 2023	SELL	$0.62 - $0.87 $4,420 - $6,203	-7,130 Reduced 22.64%	24,356 $16,000
Q1 2023 May 16, 2023	BUY	$0.83 - $1.24 $15,595 - $23,299	18,790 Added 148.0%	31,486 $27,000
Q4 2022 Feb 14, 2023	SELL	$0.77 - $1.62 $19,525 - $41,079	-25,358 Reduced 66.64%	12,696 $10,000
Q3 2022 Nov 14, 2022	SELL	$1.79 - $2.96 $83,054 - $137,341	-46,399 Reduced 54.94%	38,054 $66,000
Q2 2022 Aug 15, 2022	BUY	$1.65 - $3.13 $30,889 - $58,596	18,721 Added 28.48%	84,453 $215,000
Q1 2022 May 16, 2022	BUY	$2.1 - $3.54 $72,571 - $122,335	34,558 Added 110.86%	65,732 $201,000
Q4 2021 Feb 14, 2022	SELL	$3.04 - $6.01 $182,615 - $361,026	-60,071 Reduced 65.83%	31,174 $95,000
Q3 2021 Nov 15, 2021	BUY	$5.9 - $7.44 $200,830 - $253,250	34,039 Added 59.5%	91,245 $543,000
Q2 2021 Aug 11, 2021	SELL	$5.78 - $9.6 $184,925 - $307,142	-31,994 Reduced 35.87%	57,206 $385,000
Q1 2021 May 17, 2021	BUY	$5.67 - $12.54 $505,764 - $1.12 Million	89,200 New	89,200 $649,000

Ticker NHWK
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,661,500
Market Cap $4.11M
Description
NightHawk Biosciences, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating plat...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.